The Full Wiki

More info on LILRA3

LILRA3: Wikis

Advertisements

Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.

Encyclopedia

From Wikipedia, the free encyclopedia

edit
Leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3
Identifiers
Symbols LILRA3; CD85E; HM31; HM43; ILT6; LIR-4; LIR4; e3
External IDs OMIM604818 HomoloGene74583 GeneCards: LILRA3 Gene
RNA expression pattern
PBB GE LILRA3 206881 s at tn.png
More reference expression data
Orthologs
Species Human Mouse
Entrez 11026 n/a
Ensembl ENSG00000170866 n/a
UniProt Q8N6C8 n/a
RefSeq (mRNA) NM_006865 n/a
RefSeq (protein) NP_006856 n/a
Location (UCSC) Chr 19:
59.49 - 59.5 Mb
n/a
PubMed search [1] n/a

Leukocyte immunoglobulin-like receptor subfamily A member 3 is a protein that in humans is encoded by the LILRA3 gene.[1][2][3]

Contents

See also

References

  1. ^ Arm JP, Nwankwo C, Austen KF (Sep 1997). "Molecular identification of a novel family of human Ig superfamily members that possess immunoreceptor tyrosine-based inhibition motifs and homology to the mouse gp49B1 inhibitory receptor". J Immunol 159 (5): 2342-9. PMID 9278324.  
  2. ^ Borges L, Hsu ML, Fanger N, Kubin M, Cosman D (Apr 1998). "A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules". J Immunol 159 (11): 5192-6. PMID 9548455.  
  3. ^ "Entrez Gene: LILRA3 leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3". http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=11026.  

Further reading

  • Samaridis J, Colonna M (1997). "Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: structural evidence for new stimulatory and inhibitory pathways.". Eur. J. Immunol. 27 (3): 660–5. doi:10.1002/eji.1830270313. PMID 9079806.  
  • Cella M, Döhring C, Samaridis J, et al. (1997). "A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing.". J. Exp. Med. 185 (10): 1743–51. doi:10.1084/jem.185.10.1743. PMID 9151699.  
  • Colonna M, Navarro F, Bellón T, et al. (1997). "A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells.". J. Exp. Med. 186 (11): 1809–18. doi:10.1084/jem.186.11.1809. PMID 9382880.  
  • Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932.  
  • Wiśniewski A, Łuszczek W, Mańczak M, et al. (2004). "Distribution of LILRA3 (ILT6/LIR4) deletion in psoriatic patients and healthy controls.". Hum. Immunol. 64 (4): 458–61. doi:10.1016/S0198-8859(03)00025-9. PMID 12651072.  
  • Norman PJ, Carey BS, Stephens HA, Vaughan RW (2003). "DNA sequence variation and molecular genotyping of natural killer leukocyte immunoglobulin-like receptor, LILRA3.". Immunogenetics 55 (3): 165–71. doi:10.1007/s00251-003-0561-1. PMID 12750859.  
  • Zhang Z, Henzel WJ (2005). "Signal peptide prediction based on analysis of experimentally verified cleavage sites.". Protein Sci. 13 (10): 2819–24. doi:10.1110/ps.04682504. PMID 15340161.  
  • Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMID 15489334.  
  • Rual JF, Venkatesan K, Hao T, et al. (2005). "Towards a proteome-scale map of the human protein-protein interaction network.". Nature 437 (7062): 1173–8. doi:10.1038/nature04209. PMID 16189514.  

External links

This article incorporates text from the United States National Library of Medicine, which is in the public domain.

Advertisements

Advertisements






Got something to say? Make a comment.
Your name
Your email address
Message